Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection

NCT04477993 is registered in ClinicalTrials.gov with Vanderson Geraldo Rocha as lead sponsor.

NCT NCT04477993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04477993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Lead sponsor
Vanderson Geraldo Rocha
Phase
Phase 2/3
Overall status
Terminated
Start date
August 14, 2020
Completion date
March 29, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2, severe acute respiratory syndrome coronavirus 2